Phase II trial of 13-cis-retinoic acid for poor risk HIV-associated Kaposi's sarcoma

M. Bower*, K. Fife, D. Landau, F. Gracie, R. H. Phillips, B. G. Gazzard

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of 13-cis-retinoic acid for poor risk HIV-associated Kaposi's sarcoma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science